Duodenal Levodopa Infusion Improves Quality of Life in Advanced Parkinson’s Disease

Publisher： Karger

E-ISSN： 1660-2862|5|3-4|244-246

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.5, Iss.3-4, 2008-03, pp. : 244-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Autoradiographic Study on the Pathogenesis of Levodopa-Induced Dyskinesia: Regulation of Dopamine Transporter by Levodopa in a Rat Model of Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 9, Iss. 1, 2011-08 ,pp. : 11-17

Karger

Access to resources Recommend Favorite

Dissociating the Cognitive Effects of Levodopa versus Dopamine Agonists in a Neurocomputational Model of Learning in Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 11, Iss. 2, 2012-10 ,pp. : 102-111

Karger

Access to resources Recommend Favorite

Parkinson’s disease: clinical aspects

By Klockgether Thomas  

Cell and Tissue Research, Vol. 318, Iss. 1, 2004-10 ,pp. : 115-120

Springer Publishing Company

Access to resources Recommend Favorite

Neuronal pathology in Parkinson’s disease

By Schulz Jörg   Falkenburger Björn  

Cell and Tissue Research, Vol. 318, Iss. 1, 2004-10 ,pp. : 135-147

Springer Publishing Company

Access to resources Recommend Favorite

Gene therapy in Parkinson’s disease

By Eberhardt O.   Schulz J.  

Cell and Tissue Research, Vol. 318, Iss. 1, 2004-10 ,pp. : 243-260

Springer Publishing Company

Access to resources Recommend Favorite